LexDanaLexDanabeta
Inventor

Yoshikazu Takaoka

Inventor
Mishima-shi, JP

Overview

24→
Patents
2005–2014
Patent span
Human necessities
Primary field (CPC A)

Patents· 24 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07DHeterocyclic compounds36%
A61KPreparations for medical, dental or toiletry purposes19%
C07CAcyclic or carbocyclic compounds5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
PatentTitleYear
8,871,210'Chemokine receptor antagonists and use thereof'20148,822,459'Compound containing basic group and use thereof'20148,680,092'Nitrogenous heterocyclic compound and medicinal use thereof'20148,614,323'Chemokine receptor antagonists and use thereof'20138,604,207'Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient'20138,519,124'Chemokine receptor antagonists and use thereof'20138,410,276'Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient'20138,318,931'Chemokine receptor antagonists and use thereof'20128,293,896'Chemokine receptor antagonists and use thereof'20128,168,783'Chemokine receptor antagonists and use thereof'20128,143,404'Nitrogenous heterocylic derivative and medicine containing the same as an active ingredient'20128,124,645'LPA receptor antagonist'20127,951,816'Compound containing basic group and use thereof'20117,910,741'Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient'20117,875,745'Compounds having lysophosphatidic acid receptor antagonism and uses thereof'20117,820,682'LPA receptor antagonist'20107,498,323'Spiro-piperidine compounds and medicinal use thereof'20097,378,428'Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient'20087,361,758'Crystals of triazaspiro[5.5]undecane derivative'20087,285,552'Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient'20077,262,193'Triazaspiro[5.5]undecane derivative and pharmaceutical composition comprising the same as active ingredient'20077,119,091'Triazaspiro[5.5]undecane derivatives and pharmaceutical compositions comprising thereof, as an active ingredient'20067,053,090'Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient'20066,956,033'3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient'2005

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2005–2014Patents assigned to ONO PHARMACEUTICAL CO (23)· patent assignee history
2005–2014Based in Mishima-shi, JP· patent location history
2012–2014Patents assigned to TAKAOKA YOSHIKAZU (9)· patent assignee history
2012–2014Patents assigned to SHIBAYAMA SHIRO (8)· patent assignee history
2012–2014Patents assigned to KOKUBO MASAYA (5)· patent assignee history
2012–2014Patents assigned to OCHIAI HIROSHI (5)· patent assignee history
2013–2014Based in Osaka, JP· patent location history
2013Based in London, GB· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ONO PHARMACEUTICAL CO232005–2014
TAKAOKA YOSHIKAZUself92012–2014
SHIBAYAMA SHIRO82012–2014
KOKUBO MASAYA52012–2014
OCHIAI HIROSHI52012–2014
Locations
LocationPatentsSpan
Mishima-shi, JP192005–2014
Osaka, JP42013–2014
London, GB12013